Edarbi and Pregnancy

It is typically recommended that women not take Edarbi (azilsartan) while pregnant. This drug is considered a pregnancy Category D medication, and it has the potential to cause serious problems (in some cases, even fetal death). Before taking Edarbi, talk to your healthcare provider if you are pregnant or thinking of becoming pregnant.

Edarbi Medication Information

Can Pregnant Women Take Edarbi?

Edarbi™ (azilsartan medoxomil) is a prescription medication used in the treatment of hypertension (high blood pressure). It belongs to a class of drugs called angiotensin II receptor blockers, or ARBs for short. This medication is not recommended for use in women who are pregnant, as it can cause serious problems to an unborn child. It all but the very rarest of situations, pregnant women should not take Edarbi.

What Is Pregnancy Category D?

The U.

S. Food and Drug Administration (FDA) categorizes Edarbi as a pregnancy Category D medicine for all trimesters (previously, it was a Category C medicine for the first trimester and a Category D medicine for the second and third trimesters).

The FDA uses a category system to classify the possible risks to a fetus when a specific medicine is taken during pregnancy. Pregnancy Category D is given to medicines that have been shown to present a risk to the fetus in studies of pregnant women but may still offer benefits that outweigh the risks the drug presents. A pregnancy Category D medicine may still be given to a pregnant woman if the healthcare provider believes that the benefits to the woman outweigh the possible risks to her unborn child.

Edarbi and Pregnancy Article Continues on Next Page >